Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 4 3Phase 2 3Phase NA 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3NETWORK 2OTHER_GOV 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia 2Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1Leukemia, Lymphocytic, Chronic, B-Cell 1HIV Infections 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × VAP-cyclo protocol × Clear all
NCT03145480 2023-06-01

Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients

Northwell Health

Phase 2 Terminated
3 enrolled 5 charts
Other hematologic neoplasm

Leukemia

NCT01045889 2016-08-19

HDT-HIV

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Completed
27 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, AIDS-Related

NCT00072007 2012-05-15

Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL

Swiss Cancer Institute

Phase 2 Completed
43 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡